Literature DB >> 24036070

Outcome of redo surgical aortic valve replacement in patients 80 years and older: results from the Multicenter RECORD Initiative.

Francesco Onorati1, Fausto Biancari2, Marisa De Feo3, Giovanni Mariscalco4, Antonio Messina5, Giuseppe Santarpino6, Francesco Santini7, Cesare Beghi4, Giannantonio Nappi3, Giovanni Troise5, Theodor Fischlein6, Giancarlo Passerone7, Jeuni Heikkinen2, Giuseppe Faggian8.   

Abstract

BACKGROUND: Octogenarians undergoing surgical aortic valve replacement (AVR) after prior cardiac surgery are expected to be at high risk of adverse events. This finding has recently popularized transcatheter AVR in this cohort.
METHODS: This multicenter study includes 744 patients (99 were 80 years or older) who underwent surgical AVR after prior cardiac surgery. The outcome of octogenarians was compared with younger patients in the entire cohort and in a propensity score-matched population.
RESULTS: Octogenarians and younger patients had similar immediate outcome (in-hospital mortality, 3.0% versus 5.9%; p=0.34; stroke, 5.1% versus 6.7%; p=0.66; dialysis, 9.1% versus 6.5%; p=0.34), as confirmed also in 84 propensity score-matched pairs. Octogenarians and younger patients had similar late survival (5-year survival, 83.1% versus 78.0%; p=0.68; propensity score-adjusted relative risk [RR], 0.23; 95% confidence interval [CI], 0.59 to 1.88). Octogenarians and younger patients had similar freedom from heart failure episodes (at 5 years, 84.5% versus 89.2%; p=0.311; propensity score-adjusted RR, 1.37; 95% CI, 0.62 to 3.04) and from reoperation (at 5 years, 94.9% versus 97.9%; p=0.51; propensity score-adjusted RR, 1.93; 95% CI, 0.35 to 10.56). However, octogenarians had poorer freedom from late stroke (at 5 years, 89.8% versus 97.5%; p=0.016; propensity score-adjusted RR, 6.137; 95% CI, 1.776 to 21.208) and peripheral thromboembolism (at 5 years, 90.0% versus 98.2%; p=0.003; propensity score-adjusted RR, 4.00; 95% CI, 1.07 to 15.00).
CONCLUSIONS: Octogenarians undergoing surgical AVR after prior cardiac surgery have similar immediate postoperative outcome as younger patients, and their 5-year outcome is excellent. These data suggest that indications to undergo transcatheter AVR should not rely only on coexistence of advanced age and history of prior cardiac surgery.
Copyright © 2014 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  35

Mesh:

Year:  2013        PMID: 24036070     DOI: 10.1016/j.athoracsur.2013.09.007

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  4 in total

1.  Results of surgical aortic valve replacement and transapical transcatheter aortic valve replacement in patients with previous coronary artery bypass grafting.

Authors:  Francesco Onorati; Augusto D'Onofrio; Fausto Biancari; Stefano Salizzoni; Marisa De Feo; Marco Agrifoglio; Giovanni Mariscalco; Vincenzo Lucchetti; Antonio Messina; Francesco Musumeci; Giuseppe Santarpino; Giampiero Esposito; Francesco Santini; Paolo Magagna; Cesare Beghi; Marco Aiello; Ester Dalla Ratta; Carlo Savini; Giovanni Troise; Mauro Cassese; Theodor Fischlein; Mattia Glauber; Giancarlo Passerone; Giuseppe Punta; Tatu Juvonen; Ottavio Alfieri; Davide Gabbieri; Domenico Mangino; Andrea Agostinelli; Ugolino Livi; Omar Di Gregorio; Alessandro Minati; Mauro Rinaldi; Gino Gerosa; Giuseppe Faggian
Journal:  Interact Cardiovasc Thorac Surg       Date:  2016-03-14

2.  Parsimonious assessment for reoperative aortic valve replacement; the deterrent effect of low left ventricular ejection fraction and renal impairment.

Authors:  Maroun Yammine; Fernando Ramirez-Del Val; Julius I Ejiofor; Robert C Neely; Diana Shi; Siobhan McGurk; Sary F Aranki; Tsuyoshi Kaneko; Prem S Shekar
Journal:  Ann Cardiothorac Surg       Date:  2017-09

3.  Is the EuroSCORE II reliable to estimate operative mortality among octogenarians?

Authors:  Sophie Provenchère; Arnaud Chevalier; Walid Ghodbane; Claire Bouleti; Philippe Montravers; Dan Longrois; Bernard Iung
Journal:  PLoS One       Date:  2017-11-16       Impact factor: 3.240

4.  The use of balloon-expandable Sapien-3 valve in redo aortic valve replacement and the potential risk of left main stem occlusion.

Authors:  Thomas Theologou; Sara Clivio; Adel Younes; Stefanos Demertzis; Enrico Ferrari
Journal:  J Card Surg       Date:  2022-03-31       Impact factor: 1.778

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.